Abrocitinib Therapeutic Cheat Sheet
Abrocitinib is an oral, once-daily selective Janus kinase 1 (JAK1) inhibitor approved for moderate-to-severe atopic dermatitis. It can provide rapid improvement in pruritus and skin disease and is a useful treatment option for many patients. As an oral medication, it may also be preferred by patients who want to avoid injections. When prescribing abrocitinib, it is important to discuss laboratory …
Abrocitinib is an oral, once-daily selective Janus kinase 1 (JAK1) inhibitor approved for moderate-to-severe atopic dermatitis. It can provide rapid improvement in pruritus and skin disease and is a useful treatment option for many patients. As an oral medication, it may also be preferred by patients who want to avoid injections. When prescribing abrocitinib, it is important to discuss laboratory … 
Emily Murphy, MD, FAAD, is committed to improving care for vulvar dermatoses, which is why she founded the Vulvar Health Program at the George Washington University School of Medicine & Health Sciences. In this Next Steps in Derm interview, in partnership with the ODAC Dermatology Conference, Dr. Murphy shares what her clinical experience has taught her about diagnosing and managing vulvar der … 
In my article, “The Dermatology Job Search Timeline: Reflections from a Resident Still in the Interview Process,” I focused on what I needed to do during my last year of residency to secure a job. The job search takes up a surprising amount of space on the calendar. There are interviews, contracts, licensing, credentialing, board prep, and decisions about where to live. It is easy for the enti … 
A neonate is examined in the NICU after being born to a mother with the below findings on her hands. Which of the following are most likely to be seen in the neonate?
A. Supernumerary vertebrae with extra ribs
B. Microcephaly
C. Natal teeth
D. Pseudoparalysis
E. Hydrops fetalis
To find out the correct answer and read the explanation, click here.
This weeks question f … 
Surgery is the gold standard for skin cancer treatment, but sometimes surgery isn’t the best option. Perhaps the patient isn’t healthy enough or the patient simply refuses to go under the knife. Topical therapy is an alternative, but patient compliance is a concern. Enter fractional laser-assisted drug delivery (LADD): a non-surgical approach that enhances penetration of topical treatments, le …